The Leadership Team at Luminary Therapeutics drives the strategic vision and innovation for developing cutting-edge cell therapies. Comprised of founders and executives with expertise in science, innovation, finance, and business development, this team collaborates to advance research initiatives, secure funding, and navigate regulatory pathways, ensuring the successful transition from pre-clinical to clinical stages for novel CAR T solutions that tackle antigen escape in cancer and autoimmune diseases.
View all